Answers are grounded in this paper and cite their sources.
The study demonstrates the synthesis of pyrazoline derivatives from aryl-dioxobutanoic acids and nitrobenzohydrazides, indicating potential biological activity.
4-Aryl-2,4-dioxobutanoic acids react with 3-nitro- and 4-nitrobenzohydrazides in a 1:2 ratio to form the corresponding 3-aryl-1-(3-nitrobenzoyl)-5-(2-(3-nitrobenzoyl)hydrazinyl)-4,5-dihydro-1-pyrazole-5-carboxylic acids and 3-aryl-1-(4-nitrobenzoyl)-5-(2-(4-nitrobenzoyl)hydrazinyl)-4,5-dihydro-1-pyrazole-5-carboxylic acids, the structure of which is confirmed by X-ray diffraction analysis. The reaction proceeds under mild conditions with high yields without the use of catalysts and additives, and the isolation process does not require column chromatography. The obtained compounds are promising in terms of the manifestation of various types of biological activity.
No takes yet. Share an insight, caveat, or question.
A.A. Andreeva (2025) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: